Emulsion and liposome-based adjuvanted R21 vaccine formulations mediate protection against malaria through distinct immune mechanisms.
Reinke S. et al, (2023), Cell reports. Medicine
TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases.
Luchner M. et al, (2021), Pharmaceutics, 13
Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology
Codd AS. et al, (2021), Oxford Open Immunology, 2
The role and uses of antibodies in COVID-19 infections: a living review
Scourfield DO. et al, (2021), Oxford Open Immunology, 2
Mucosal immune responses in COVID19 - a living review.
Pearson CF. et al, (2021), Oxf Open Immunol, 2
Inflammasome-Mediated Immunogenicity of Clinical and Experimental Vaccine Adjuvants.
Reinke S. et al, (2020), Vaccines, 8
Technological Approaches for Improving Vaccination Compliance and Coverage.
Lemoine C. et al, (2020), Vaccines, 8
Investigating the Effect of Encapsulation Processing Parameters on the Viability of Therapeutic Viruses in Electrospraying
Sanders T. et al, (2020), Pharmaceutics, 12, 388 - 388
Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease
Elshina E. et al, (2019), Vaccine, 37, 502 - 509
Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
Coughlan L. et al, (2018), EBioMedicine, 29, 146 - 154
Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
Milicic A. et al, (2017), Scientific Reports, 7
Development of persistent gastrointestinal S. aureus carriage in mice
Flaxman A. et al, (2017), Scientific Reports, 7
The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens
Diemen PMV. et al, (2017), Scientific Reports, 7
Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy
Walters AA. et al, (2015), Journal of Pharmacy and Pharmacology, 67, 400 - 408
Immune responses associated with homologous protection conferred by commercial vaccines for control of avian pathogenic Escherichia coli in turkeys
Sadeyen J-R. et al, (2015), Veterinary Research, 46, 5 - 5
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
Warimwe GM. et al, (2013), Virology Journal, 10
A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years
Antrobus RD. et al, (2012), PLoS ONE, 7, e48322 - e48322
Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity
Reyes-Sandoval A. et al, (2012), Molecular Therapy, 20, 1633 - 1647
Small Cationic DDA:TDB Liposomes as Protein Vaccine Adjuvants Obviate the Need for TLR Agonists in Inducing Cellular and Humoral Responses
Milicic A. et al, (2012), PLoS ONE, 7, e34255 - e34255